Tickerplace logo

Tickerplace

Pliant Therapeutics, Inc. logo

PLRXPliant Therapeutics, Inc.

PLRX Stock Price, Valuation & Chart | Pliant Therapeutics, Inc.

Compare
$1.160+0.05 (+4.50%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyPLRX intrinsic valuePLRX calculated fair value vs price
OverviewFinancialsDividendsRatios

PLRX Historical price chart

PLRX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization71.83M
PE Ratio-0.79
EPS-1.46
Trading Volume740.06K
Today's High/Low1.17/1.11
Dividend Yield0.00
52 Week High/Low1.95/1.02
Shares Outstanding61.92M
PLRX Financial Statement
PLRX Analyst ratings
PLRX Analysis & performance metrics

PLRX Company profile

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related…

PLRX Management team

Management
Rik Derynck Ph.D.
Scientific Founder & Member of Scientific Advisory Board
Bill DeGrado Ph.D.
Scientific Founder & Member of Scientific Advisory Board
Christopher S. Keenan
Vice President of Investor Relations & Corporate Communications
Johannes P. Hull J.D.
Chief Business Officer
Eric A. Lefebvre M.D.
Chief Medical Officer
Dean Sheppard M.D.
Scientific Founder & Member of Scientific Advisory Board
Hal Chapman M.D.
Scientific Founder & Member of Scientific Advisory Board
Delphine Imbert Ph.D.
Chief Technical Officer
Total 8 executives

PLRX Frequently asked questions

What is Pliant Therapeutics, Inc. (PLRX) Stock Price?

Current stock price of Pliant Therapeutics, Inc. (PLRX) stock is $1.160. The stock price is +4.50% higher in the session. The intraday range can be seen from this page. Volume of Pliant Therapeutics, Inc. (PLRX) stock is 740.06K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Pliant Therapeutics, Inc. (PLRX) stock price going up or down today?

The stock price of Pliant Therapeutics, Inc. (PLRX) can change with earnings, company news, and overall market sentiment. Pliant Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Pliant Therapeutics, Inc. stock expensive at its current price?

Whether Pliant Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PLRX on this page is -0.79. EPS on this page is -1.46. Compare those figures with peers and growth expectations before deciding if the current Pliant Therapeutics, Inc. price is justified.

How has the stock price of Pliant Therapeutics, Inc. (PLRX) performed historically?

Historical performance for Pliant Therapeutics, Inc. (PLRX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PLRX reacted to past earnings and market events.

Should I buy Pliant Therapeutics, Inc. (PLRX) stock, at this price?

Buying Pliant Therapeutics, Inc. (PLRX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.